Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Demaria

Showing results (131-140 of 157) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|November 11, 2017
The Future of RadiobiologyDavid G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Science Translational Medicine|March 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancerErik Wennerberg, Sumit Mukherjee, Sheila Spada, et al.
Cancers|August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to ImmunoscoreJoseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
Journal of Translational Medicine|December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Nature Communications|July 22, 2021
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amineCristina C Clement, Angelo D'Alessandro, Sangeetha Thangaswamy, et al.
Oncoimmunology|December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conferencePierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
NPJ Breast Cancer|May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsJan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.
Journal of Translational Medicine|November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Pageof 16

Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|November 11, 2017
The Future of RadiobiologyDavid G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Journal of Translational Medicine|September 7, 2020
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)Paolo A Ascierto, Igor Puzanov, Sanjiv S Agarwala, et al.
Seminars in Cancer Biology|October 13, 2017
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerMaria Vittoria Dieci, Nina Radosevic-Robin, Susan Fineberg, et al.
Science Translational Medicine|March 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancerErik Wennerberg, Sumit Mukherjee, Sheila Spada, et al.
Cancers|August 26, 2023
Multi-Institutional Evaluation of Pathologists' Assessment Compared to ImmunoscoreJoseph Willis, Robert A Anders, Toshihiko Torigoe, et al.
Journal of Translational Medicine|December 2, 2015
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014Paolo A Ascierto, Michael Atkins, Carlo Bifulco, et al.
Nature Communications|July 22, 2021
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amineCristina C Clement, Angelo D'Alessandro, Sangeetha Thangaswamy, et al.
Oncoimmunology|December 19, 2024
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7<sup>th</sup> immunorad conferencePierre-Antoine Laurent, Fabrice André, Alexandre Bobard, et al.
NPJ Breast Cancer|May 22, 2020
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trialsJan Hudeček, Leonie Voorwerk, Maartje van Seijen, et al.
Journal of Translational Medicine|November 17, 2016
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015Paolo A Ascierto, Sanjiv Agarwala, Gerardo Botti, et al.
Pageof 16